Ariosa Diagnostics said today that it tested over 40,000 pregnant women with its sequencing-based noninvasive Harmony Prenatal test for fetal aneuploidies in the third quarter of 2013 and over 150,000 women since its commercial launch last year.

The San Jose, Calif.-based privately-held company launched its test in May 2012 through a collaboration with Laboratory Corporation of America and has since expanded into 50 countries across six continents.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.